Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Carrizosa González, Jorge"'
Publikováno v:
Villegas MV, Lolans K, Correa A, Suarez CJ, Lopez JA, Vallejo M, et al. First detection of the plasmid-mediated class a carbapenemase KPC-2 in clinical isolates of Klebsiella pneumoniae from South America. Antimicrob Agents Chemother. 2006 Aug 1;50(8):2880–2.
Bassetti M, Giacobbe DR, Giamarellou H, Viscoli C, Daikos GL, Dimopoulos G, et al. Management of KPC-producing Klebsiella pneumoniae infections. Clinical Microbiology and Infection. 2017 Feb;133–44
Watkins RR, Bonomo RA. Overview: Global and Local Impact of Antibiotic Resistance. Vol. 30, Infectious Disease Clinics of North America. 2016. p. 313–22.
Ocampo A, Vargas C, Sierra P, Biomédica AC-, 2015 undefined. Caracterización molecular de un brote de Klebsiella pneumoniae resistente a carbapenémicos en un hospital de alto nivel de complejidad de Medellín. redalyc.org
Fernández-Canigia L, Dowzicky MJ. Susceptibility of important Gram-negative pathogens to tigecycline and other antibiotics in Latin America between 2004 and 2010. Ann Clin Microbiol Antimicrob. 2012 Oct 22;11(1):29
Park R, O’Brien TF, Huang SS, Baker MA, Yokoe DS, Kulldorff M, et al. Statistical detection of geographic clusters of resistant Escherichia coli in a regional network with WHONET and SaTScan. Expert Rev Anti Infect Ther. 2016 Nov 6;14(11):1097–107.
Livermore DM. Current epidemiology and growing resistance of gram-negative pathogens. Korean J Intern Med. 2012 Jun;27(2):128–42.
Lopez JA, Correa A, Navon-Venezia S, Correa AL, Torres JA, Briceño DF, et al. Intercontinental spread from Israel to Colombia of a KPC-3-producing Klebsiella pneumoniae strain. Clin Microbiol Infect. 2011 Jan;17(1):52–6
Costerton JW. The structure and function of the cell envelope of gram-negative bacteria. Rev Can Biol. 1970 Sep;29(3):299–316
Bratu S, Landman D, Haag R, Recco R, Eramo A, Alam M, et al. Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium. Arch Intern Med. 2005 Jun 27;165(12):1430–5.
Ambler RP. The structure of beta-lactamases. Philos Trans R Soc Lond B Biol Sci. 1980 May 16;289(1036):321–31
Rodloff AC, Goldstein EJC, Torres A. Two decades of imipenem therapy. J Antimicrob Chemother. 2006 Sep 6;58(5):916–29
Yigit H, Queenan AM, Anderson GJ, Domenech-Sanchez A, Biddle JW, Steward CD, et al. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella 53 pneumoniae. Antimicrob Agents Chemother. 2001 Apr 1;45(4):1151–61.
Villegas MV, Lolans K, Correa A, Kattan JN, Lopez JA, Quinn JP, et al. First identification of Pseudomonas aeruginosa isolates producing a KPC-type carbapenem-hydrolyzing beta-lactamase. Antimicrob Agents Chemother. 2007 Apr 1;51(4):1553–5.
Heitman M.D., Ph.D. J. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. Mycopathologia. 2000;149(1):47–8.
Munoz-Price LS, Poirel L, Bonomo RA, Schwaber MJ, Daikos GL, Cormican M, et al. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis. 2013 Sep;13(9):785–96.
Mathers AJ, Carroll J, Sifri CD, Hazen KC. Modified Hodge test versus indirect carbapenemase test: prospective evaluation of a phenotypic assay for detection of Klebsiella pneumoniae carbapenemase (KPC) in Enterobacteriaceae. J Clin Microbiol. 2013 Apr 1;51(4):1291–3.
Anderson KF, Lonsway DR, Rasheed JK, Biddle J, Jensen B, McDougal LK, et al. Evaluation of Methods To Identify the Klebsiella pneumoniae Carbapenemase in Enterobacteriaceae. J Clin Microbiol. 2007 Aug 1;45(8):2723–5
Hirsch EB, Tam VH. Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection. J Antimicrob Chemother. 2010 Jun;65(6):1119–25.
Rapp RP, Urban C. Klebsiella pneumoniae carbapenemases in Enterobacteriaceae: history, evolution, and microbiology concerns. Pharmacotherapy. 2012 May;32(5):399–407.
Zarkotou O, Pournaras S, Tselioti P, Dragoumanos V, Pitiriga V, Ranellou K, et al. Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment. Clin Microbiol Infect. 2011 Dec;17(12):1798–803.
Gasink LB, Edelstein PH, Lautenbach E, Synnestvedt M, Fishman NO. Risk factors and clinical impact of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae. Infect Control Hosp Epidemiol. 2009 Dec 2;30(12):1180–5.
Tumbarello M, Trecarichi EM, Tumietto F, Del Bono V, De Rosa FG, Bassetti M, et al. Predictive models for identification of hospitalized patients harboring KPC-producing Klebsiella pneumoniae. Antimicrob Agents Chemother. 2014 Jun;58(6):3514–20.
Papadimitriou-Olivgeris M, Marangos M, Christofidou M, Fligou F, Bartzavali C, Panteli ES, et al. Risk factors for infection and predictors of mortality among patients with KPC-producing Klebsiella pneumoniae bloodstream infections in the intensive care unit. Scand J Infect Dis. 2014 Sep 14;46(9):642–8
Camargo JF, Tobón GJ, Fonseca N, Diaz JL, Uribe M, Molina F, et al. Autoimmune rheumatic diseases in the intensive care unit: experience from a tertiary referral hospital and review of the literature. Lupus. 2005 Apr 2;14(4):315–20.
Papadimitriou-Olivgeris M, Marangos M, Fligou F, Christofidou M, Sklavou C, Vamvakopoulou S, et al. KPC-producing Klebsiella pneumoniae enteric colonization acquired during intensive care unit stay: the significance of risk factors for its development and its impact on mortality. Diagn Microbiol Infect Dis. 2013 Oct;77(2):169–73.
Falcone M, Russo A, Iacovelli A, Restuccia G, Ceccarelli G, Giordano A, et al. Predictors of outcome in ICU patients with septic shock caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae. Clin Microbiol Infect. 2016 May;22(5):444–50.
Fraenkel-Wandel Y, Raveh-Brawer D, Wiener-Well Y, Yinnon AM, Assous M V. Mortality due to bla KPC Klebsiella pneumoniae bacteraemia. J Antimicrob Chemother. 2016 Apr;71(4):1083–7.
Papadimitriou-Olivgeris M, Fligou F, Bartzavali C, Zotou A, Spyropoulou A, Koutsileou K, et al. Carbapenemase-producing Klebsiella pneumoniae bloodstream infection in critically ill patients: risk factors and predictors of mortality. Eur J Clin Microbiol Infect Dis. 2017 Jul 19;36(7):1125–31.
da Silva KE, Maciel WG, Sacchi FPC, Carvalhaes CG, Rodrigues-Costa F, da Silva ACR, et al. Risk factors for KPC-producing Klebsiella pneumoniae: watch out for surgery. J Med Microbiol. 2016 Jun 1;65(6):547–53.
Zhang Y, Wang Q, Yin Y, Chen H, Jin L, Gu B, et al. Epidemiology of Carbapenem-Resistant Enterobacteriaceae Infections: Report from the China CRE Network. Antimicrob Agents Chemother. 2018 Feb 4;62(2):e01882-17.
Yoon E-J, Kim JO, Kim D, Lee H, Yang JW, Lee KJ, et al. Klebsiella pneumoniaeCarbapenemase Producers in South Korea between 2013 and 2015. Front Microbiol. 2018 Jan 25;9:56.
De Waele JJ, Akova M, Antonelli M, Canton R, Carlet J, De Backer D, et al. Antimicrobial resistance and antibiotic stewardship programs in the ICU: insistence and persistence in the fight against resistance. A position statement from ESICM/ESCMID/WAAAR round table on multi-drug resistance. Intensive Care Med. 2018 Feb;44(2):189–96.
Tumbarello M, Trecarichi EM, De Rosa FG, Giannella M, Giacobbe DR, Bassetti M, et al. Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study. J Antimicrob Chemother. 2015 Jul;70(7):2133–43.
León AL, Hoyos NA, Barrera LI, De La Rosa G, Dennis R, Dueñas C, et al. Clinical course of sepsis, severe sepsis, and septic shock in a cohort of infected patients from ten Colombian hospitals. BMC Infect Dis. 2013 Jul 24;13(1):345.
Levy MM, Artigas A, Phillips GS, Rhodes A, Beale R, Osborn T, et al. Outcomes of the Surviving Sepsis Campaign in intensive care units in the USA and Europe: a prospective cohort study. Lancet Infect Dis. 2012 Dec;12(12):919–24.
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
Bassetti M, Giacobbe DR, Giamarellou H, Viscoli C, Daikos GL, Dimopoulos G, et al. Management of KPC-producing Klebsiella pneumoniae infections. Clinical Microbiology and Infection. 2017 Feb;133–44
Watkins RR, Bonomo RA. Overview: Global and Local Impact of Antibiotic Resistance. Vol. 30, Infectious Disease Clinics of North America. 2016. p. 313–22.
Ocampo A, Vargas C, Sierra P, Biomédica AC-, 2015 undefined. Caracterización molecular de un brote de Klebsiella pneumoniae resistente a carbapenémicos en un hospital de alto nivel de complejidad de Medellín. redalyc.org
Fernández-Canigia L, Dowzicky MJ. Susceptibility of important Gram-negative pathogens to tigecycline and other antibiotics in Latin America between 2004 and 2010. Ann Clin Microbiol Antimicrob. 2012 Oct 22;11(1):29
Park R, O’Brien TF, Huang SS, Baker MA, Yokoe DS, Kulldorff M, et al. Statistical detection of geographic clusters of resistant Escherichia coli in a regional network with WHONET and SaTScan. Expert Rev Anti Infect Ther. 2016 Nov 6;14(11):1097–107.
Livermore DM. Current epidemiology and growing resistance of gram-negative pathogens. Korean J Intern Med. 2012 Jun;27(2):128–42.
Lopez JA, Correa A, Navon-Venezia S, Correa AL, Torres JA, Briceño DF, et al. Intercontinental spread from Israel to Colombia of a KPC-3-producing Klebsiella pneumoniae strain. Clin Microbiol Infect. 2011 Jan;17(1):52–6
Costerton JW. The structure and function of the cell envelope of gram-negative bacteria. Rev Can Biol. 1970 Sep;29(3):299–316
Bratu S, Landman D, Haag R, Recco R, Eramo A, Alam M, et al. Rapid spread of carbapenem-resistant Klebsiella pneumoniae in New York City: a new threat to our antibiotic armamentarium. Arch Intern Med. 2005 Jun 27;165(12):1430–5.
Ambler RP. The structure of beta-lactamases. Philos Trans R Soc Lond B Biol Sci. 1980 May 16;289(1036):321–31
Rodloff AC, Goldstein EJC, Torres A. Two decades of imipenem therapy. J Antimicrob Chemother. 2006 Sep 6;58(5):916–29
Yigit H, Queenan AM, Anderson GJ, Domenech-Sanchez A, Biddle JW, Steward CD, et al. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella 53 pneumoniae. Antimicrob Agents Chemother. 2001 Apr 1;45(4):1151–61.
Villegas MV, Lolans K, Correa A, Kattan JN, Lopez JA, Quinn JP, et al. First identification of Pseudomonas aeruginosa isolates producing a KPC-type carbapenem-hydrolyzing beta-lactamase. Antimicrob Agents Chemother. 2007 Apr 1;51(4):1553–5.
Heitman M.D., Ph.D. J. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. Mycopathologia. 2000;149(1):47–8.
Munoz-Price LS, Poirel L, Bonomo RA, Schwaber MJ, Daikos GL, Cormican M, et al. Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases. Lancet Infect Dis. 2013 Sep;13(9):785–96.
Mathers AJ, Carroll J, Sifri CD, Hazen KC. Modified Hodge test versus indirect carbapenemase test: prospective evaluation of a phenotypic assay for detection of Klebsiella pneumoniae carbapenemase (KPC) in Enterobacteriaceae. J Clin Microbiol. 2013 Apr 1;51(4):1291–3.
Anderson KF, Lonsway DR, Rasheed JK, Biddle J, Jensen B, McDougal LK, et al. Evaluation of Methods To Identify the Klebsiella pneumoniae Carbapenemase in Enterobacteriaceae. J Clin Microbiol. 2007 Aug 1;45(8):2723–5
Hirsch EB, Tam VH. Detection and treatment options for Klebsiella pneumoniae carbapenemases (KPCs): an emerging cause of multidrug-resistant infection. J Antimicrob Chemother. 2010 Jun;65(6):1119–25.
Rapp RP, Urban C. Klebsiella pneumoniae carbapenemases in Enterobacteriaceae: history, evolution, and microbiology concerns. Pharmacotherapy. 2012 May;32(5):399–407.
Zarkotou O, Pournaras S, Tselioti P, Dragoumanos V, Pitiriga V, Ranellou K, et al. Predictors of mortality in patients with bloodstream infections caused by KPC-producing Klebsiella pneumoniae and impact of appropriate antimicrobial treatment. Clin Microbiol Infect. 2011 Dec;17(12):1798–803.
Gasink LB, Edelstein PH, Lautenbach E, Synnestvedt M, Fishman NO. Risk factors and clinical impact of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae. Infect Control Hosp Epidemiol. 2009 Dec 2;30(12):1180–5.
Tumbarello M, Trecarichi EM, Tumietto F, Del Bono V, De Rosa FG, Bassetti M, et al. Predictive models for identification of hospitalized patients harboring KPC-producing Klebsiella pneumoniae. Antimicrob Agents Chemother. 2014 Jun;58(6):3514–20.
Papadimitriou-Olivgeris M, Marangos M, Christofidou M, Fligou F, Bartzavali C, Panteli ES, et al. Risk factors for infection and predictors of mortality among patients with KPC-producing Klebsiella pneumoniae bloodstream infections in the intensive care unit. Scand J Infect Dis. 2014 Sep 14;46(9):642–8
Camargo JF, Tobón GJ, Fonseca N, Diaz JL, Uribe M, Molina F, et al. Autoimmune rheumatic diseases in the intensive care unit: experience from a tertiary referral hospital and review of the literature. Lupus. 2005 Apr 2;14(4):315–20.
Papadimitriou-Olivgeris M, Marangos M, Fligou F, Christofidou M, Sklavou C, Vamvakopoulou S, et al. KPC-producing Klebsiella pneumoniae enteric colonization acquired during intensive care unit stay: the significance of risk factors for its development and its impact on mortality. Diagn Microbiol Infect Dis. 2013 Oct;77(2):169–73.
Falcone M, Russo A, Iacovelli A, Restuccia G, Ceccarelli G, Giordano A, et al. Predictors of outcome in ICU patients with septic shock caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae. Clin Microbiol Infect. 2016 May;22(5):444–50.
Fraenkel-Wandel Y, Raveh-Brawer D, Wiener-Well Y, Yinnon AM, Assous M V. Mortality due to bla KPC Klebsiella pneumoniae bacteraemia. J Antimicrob Chemother. 2016 Apr;71(4):1083–7.
Papadimitriou-Olivgeris M, Fligou F, Bartzavali C, Zotou A, Spyropoulou A, Koutsileou K, et al. Carbapenemase-producing Klebsiella pneumoniae bloodstream infection in critically ill patients: risk factors and predictors of mortality. Eur J Clin Microbiol Infect Dis. 2017 Jul 19;36(7):1125–31.
da Silva KE, Maciel WG, Sacchi FPC, Carvalhaes CG, Rodrigues-Costa F, da Silva ACR, et al. Risk factors for KPC-producing Klebsiella pneumoniae: watch out for surgery. J Med Microbiol. 2016 Jun 1;65(6):547–53.
Zhang Y, Wang Q, Yin Y, Chen H, Jin L, Gu B, et al. Epidemiology of Carbapenem-Resistant Enterobacteriaceae Infections: Report from the China CRE Network. Antimicrob Agents Chemother. 2018 Feb 4;62(2):e01882-17.
Yoon E-J, Kim JO, Kim D, Lee H, Yang JW, Lee KJ, et al. Klebsiella pneumoniaeCarbapenemase Producers in South Korea between 2013 and 2015. Front Microbiol. 2018 Jan 25;9:56.
De Waele JJ, Akova M, Antonelli M, Canton R, Carlet J, De Backer D, et al. Antimicrobial resistance and antibiotic stewardship programs in the ICU: insistence and persistence in the fight against resistance. A position statement from ESICM/ESCMID/WAAAR round table on multi-drug resistance. Intensive Care Med. 2018 Feb;44(2):189–96.
Tumbarello M, Trecarichi EM, De Rosa FG, Giannella M, Giacobbe DR, Bassetti M, et al. Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study. J Antimicrob Chemother. 2015 Jul;70(7):2133–43.
León AL, Hoyos NA, Barrera LI, De La Rosa G, Dennis R, Dueñas C, et al. Clinical course of sepsis, severe sepsis, and septic shock in a cohort of infected patients from ten Colombian hospitals. BMC Infect Dis. 2013 Jul 24;13(1):345.
Levy MM, Artigas A, Phillips GS, Rhodes A, Beale R, Osborn T, et al. Outcomes of the Surviving Sepsis Campaign in intensive care units in the USA and Europe: a prospective cohort study. Lancet Infect Dis. 2012 Dec;12(12):919–24.
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
Introducción: Las infecciones son uno de los motivos de ingreso más frecuentes a la unidad de cuidado intensivo. A su vez las infecciones asociadas al cuidado de la salud de gérmenes resistentes pueden presentarse dentro del espectro de condicione
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::483c57bcd690814e789c375391404b35
Autor:
DeZubiría, Eduardo, DeZubiría, Alberto, Carrizosa González, Jorge, Sánchez Muñoz, José Alexander
Publikováno v:
Bouachour G, Roy PM, Tirot P, et al. Prognosis of systemic diseases diagnosed in intensive care units. Presse Med 1996;25:837– 41.
Kollef MH, Enzenauer RJ. Predicting outcome from intensive care for patients with rheumatologic diseases. J Rheumatol 1992;19:1260– 62.
Godeau B, Mortier E, Roy PM, et al. Short and longterm outcomes from patients with systemic rheumatoid diseases admitted to intensive care units: a prognostic study of 181 patients. J Rheumatol 1997;24(7):1317–23.
Thong BY. Tai DY, Goh SK, et al. An audit of patients with rheumatic disease requiring medical intensive care. Ann Acad Med Singapore 2001;30:254–9.
Lane SK, Gravel JW. Clinical utility of common serum rheumatological tests. Am Fam Physician 2002;65:1073–80.
Egerer K, Feist E, Rohr U, et al. Increased serum soluble CD14, ICAM-1 and E-selectin correlate with disease activity and prognosis in systemic lupus erythematosus. Lupus 2000;9:614 –21.
Eberhard OK, Haubitz M, Brunkhorst FM, et al. Usefulness of prolactin for differentiation between activity of systemic autoimmune disease (systemic lupus erythematosus / systemic antineutrophil cytoplasmic antibody-associated vasculitis) and invasive bacterial infection. Arthritis Rheum 1997;40:1250– 6.
Ter Borg EJ, Horst G, Limburg PC, et al. C-reactive protein levels during disease exacerbations and infections in systemic lupus erythematosus: a prospective longitudinal study. J Rheumatol 1990;17:1642–8.
Shin KC, Lee YJ, Kang SW, et al. Serum procalcitonin measurement for detection of intercurrent infection in febrile patients with SLE. Ann Rheum Dis 2001;60:988–99.
Schwenger V, Sis J, Breitbart A, et al. CRP levels in autoimmune disease can be specified by measurement of procalcitonin. Infection 1998;26:274– 6.
Scmitt WH, Gross WL. Vasculitis in the seriously ill patient: diagnostic approaches and therapeutic options in ANCA-associated vasculitis. Kidney Int 1998;64(Suppl):S39– 44.
Brewer EJ, Nickeson RW, Rossen RD, et al. Plasma exchange in selected patients with juvenile rheumatoid arthritis. J Pediatr 1981;98:194–200.
Ball JA, Young KR. Pulmonary manifestations of Goodpasture’s syndrome: antiglomerular basement membrane disease and related disorders. Clin Chest Med 1998;19:777–91.
Dweik RA, Arroliga AC, Cash JM. Alveolar hemorrhage in patients with rheumatic disease. Rheum Dis Clin North Am 1997;23:395–410.
Langford CA, Van Waes C. Upper airway obstruction in the rheumatic diseases. Rheum Dis Clin North Am 1997;23:345– 63.
Daum TE, Specks U, Colby TV, et al. Tracheobronchial involvement in Wegener’s granulomatosis. Am J Respir Crit Care Med 1995;151(2 Pt 1):522–6.
Gluth MB, Shinners PA, Kasperbauer JL. Subglottic stenosis associated with Wegener’s granulomatosis. Laryngoscope 2003;113(8):1304–7.
Bandi V, Munnur U, Braman SS. Airway problems in patients with rheumatologic disorders. Crit Care Clin 2002; 18 (4): 749-65.
Geterud A, Bake B, Berthelsen B, et al. Laryngeal involvement in rheumatoid arthritis. Acta Otolaryngol 1991;111:990– 8.
Wattenmaker I, Concepcion M, Hibberd P, et al. Upper-airway obstruction and perioperative management of the airway in patients managed with posterior operations on the cervical spine for rheumatoid arthritis [see comments]. Journal of Bone and Joint Surgery 1994;76:360– 5.
Jacobs JC, Hui RM. Cricoarytenoid arthritis and airway obstruction in juvenile rheumatoid arthritis. Pediatrics 1977;59:292– 4.
Toomey TM, Snyder GC, Maenza RM. Acute epiglottitis due to systemic lupus erythematosus. Laryngoscope 1974;86:734–8.
Agah R, Bandi V, Guntupalli KK. Angioedema: the role of ACE inhibitors and factors associated with poor clinical outcome. Intensive Care Med 1997;23(7):793– 6.
Marbach JJ. Rheumatoid arthritis of the temporomandibular joints. Ann Rheum Dis 1967;26: 538– 43.
Kauppi M, Hakala M. Prevalence of cervical spine subluxations and dislocations in a community based rheumatoid arthritis population. Scand J Rheumatol 1994;23(3):133– 6
Kanter GJ, Barash PG. Undiagnosed scleroderma in a patient with a difficult airway. Yale J Biol Med 1998;71:31–3.
Thompson J, Conklin K. Anesthetic management of a pregnant patient with scleroderma. Anesthesiology 1983;59:69.
Roberts KW, Solgonick RM. A modification of retrograde wire-guided, fiberoptic-assisted endotracheal intubation in a patient with ankylosing spondylitis. Anesth Analg 1996;82:1290– 1.
Polychronopoulos VS, Prakash UB, Golbin JM, et al. Airway involvement in Wegener's granulomatosis. Rheum Dis Clin North Am 2007; 33:755.
Pourrat O, Bureau JM, Hira M, et al. Outcome of patients with systemic rheumatic disease admitted to intensive care units: a retrospective study of 39 cases. Rev Med Interne 2000;21:147– 51.
Traub YM, Shapiro AP, Rodnan GP, et al. Hypertension and renal failure (scleroderma renal crisis) in progressive systemic sclerosis. Review of a 25 year experience with 68 cases. Medicine (Baltimore) 1983;62:335– 52.
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
Kollef MH, Enzenauer RJ. Predicting outcome from intensive care for patients with rheumatologic diseases. J Rheumatol 1992;19:1260– 62.
Godeau B, Mortier E, Roy PM, et al. Short and longterm outcomes from patients with systemic rheumatoid diseases admitted to intensive care units: a prognostic study of 181 patients. J Rheumatol 1997;24(7):1317–23.
Thong BY. Tai DY, Goh SK, et al. An audit of patients with rheumatic disease requiring medical intensive care. Ann Acad Med Singapore 2001;30:254–9.
Lane SK, Gravel JW. Clinical utility of common serum rheumatological tests. Am Fam Physician 2002;65:1073–80.
Egerer K, Feist E, Rohr U, et al. Increased serum soluble CD14, ICAM-1 and E-selectin correlate with disease activity and prognosis in systemic lupus erythematosus. Lupus 2000;9:614 –21.
Eberhard OK, Haubitz M, Brunkhorst FM, et al. Usefulness of prolactin for differentiation between activity of systemic autoimmune disease (systemic lupus erythematosus / systemic antineutrophil cytoplasmic antibody-associated vasculitis) and invasive bacterial infection. Arthritis Rheum 1997;40:1250– 6.
Ter Borg EJ, Horst G, Limburg PC, et al. C-reactive protein levels during disease exacerbations and infections in systemic lupus erythematosus: a prospective longitudinal study. J Rheumatol 1990;17:1642–8.
Shin KC, Lee YJ, Kang SW, et al. Serum procalcitonin measurement for detection of intercurrent infection in febrile patients with SLE. Ann Rheum Dis 2001;60:988–99.
Schwenger V, Sis J, Breitbart A, et al. CRP levels in autoimmune disease can be specified by measurement of procalcitonin. Infection 1998;26:274– 6.
Scmitt WH, Gross WL. Vasculitis in the seriously ill patient: diagnostic approaches and therapeutic options in ANCA-associated vasculitis. Kidney Int 1998;64(Suppl):S39– 44.
Brewer EJ, Nickeson RW, Rossen RD, et al. Plasma exchange in selected patients with juvenile rheumatoid arthritis. J Pediatr 1981;98:194–200.
Ball JA, Young KR. Pulmonary manifestations of Goodpasture’s syndrome: antiglomerular basement membrane disease and related disorders. Clin Chest Med 1998;19:777–91.
Dweik RA, Arroliga AC, Cash JM. Alveolar hemorrhage in patients with rheumatic disease. Rheum Dis Clin North Am 1997;23:395–410.
Langford CA, Van Waes C. Upper airway obstruction in the rheumatic diseases. Rheum Dis Clin North Am 1997;23:345– 63.
Daum TE, Specks U, Colby TV, et al. Tracheobronchial involvement in Wegener’s granulomatosis. Am J Respir Crit Care Med 1995;151(2 Pt 1):522–6.
Gluth MB, Shinners PA, Kasperbauer JL. Subglottic stenosis associated with Wegener’s granulomatosis. Laryngoscope 2003;113(8):1304–7.
Bandi V, Munnur U, Braman SS. Airway problems in patients with rheumatologic disorders. Crit Care Clin 2002; 18 (4): 749-65.
Geterud A, Bake B, Berthelsen B, et al. Laryngeal involvement in rheumatoid arthritis. Acta Otolaryngol 1991;111:990– 8.
Wattenmaker I, Concepcion M, Hibberd P, et al. Upper-airway obstruction and perioperative management of the airway in patients managed with posterior operations on the cervical spine for rheumatoid arthritis [see comments]. Journal of Bone and Joint Surgery 1994;76:360– 5.
Jacobs JC, Hui RM. Cricoarytenoid arthritis and airway obstruction in juvenile rheumatoid arthritis. Pediatrics 1977;59:292– 4.
Toomey TM, Snyder GC, Maenza RM. Acute epiglottitis due to systemic lupus erythematosus. Laryngoscope 1974;86:734–8.
Agah R, Bandi V, Guntupalli KK. Angioedema: the role of ACE inhibitors and factors associated with poor clinical outcome. Intensive Care Med 1997;23(7):793– 6.
Marbach JJ. Rheumatoid arthritis of the temporomandibular joints. Ann Rheum Dis 1967;26: 538– 43.
Kauppi M, Hakala M. Prevalence of cervical spine subluxations and dislocations in a community based rheumatoid arthritis population. Scand J Rheumatol 1994;23(3):133– 6
Kanter GJ, Barash PG. Undiagnosed scleroderma in a patient with a difficult airway. Yale J Biol Med 1998;71:31–3.
Thompson J, Conklin K. Anesthetic management of a pregnant patient with scleroderma. Anesthesiology 1983;59:69.
Roberts KW, Solgonick RM. A modification of retrograde wire-guided, fiberoptic-assisted endotracheal intubation in a patient with ankylosing spondylitis. Anesth Analg 1996;82:1290– 1.
Polychronopoulos VS, Prakash UB, Golbin JM, et al. Airway involvement in Wegener's granulomatosis. Rheum Dis Clin North Am 2007; 33:755.
Pourrat O, Bureau JM, Hira M, et al. Outcome of patients with systemic rheumatic disease admitted to intensive care units: a retrospective study of 39 cases. Rev Med Interne 2000;21:147– 51.
Traub YM, Shapiro AP, Rodnan GP, et al. Hypertension and renal failure (scleroderma renal crisis) in progressive systemic sclerosis. Review of a 25 year experience with 68 cases. Medicine (Baltimore) 1983;62:335– 52.
Repositorio EdocUR-U. Rosario
Universidad del Rosario
instacron:Universidad del Rosario
Introducción y objetivos: Las enfermedades autoinmunes en cuidado intensivo están relacionadas con tasas de mortalidad elevadas. El propósito del presente estudio fue buscar factores asociados a mortalidad en estos pacientes. Materiales y métodos
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e83c8478eb59520515e54e48e2da28a0
Autor:
Nieto Estrada, Victor Hugo, Gil Valencia, Bladimir Alejandro, Garay-Fernandez, Manuel, Molina Saldarriaga, Francisco José, Camargo Rubio, Rubén Dario, Dueñas Castell, Carmelo, Pizarro Gómez, Camilo, Pereira Paternina, Fernando José, Vergara Ramírez, Peter, Carrizosa González, Jorge Armando, Molano Franco, Daniel Leonardo, Rojas Díaz, Ever Leonardo, Borre Naranjo, Diana Patricia, Correa Pérez, Liliana Paola, Gómez Vanegas, Carmen Lorena, Sánchez Lozano, Martha Liliana, Bello Muñoz, Camilo Andrés, Borja Large, Erick Alexander, Olaya Garay, Sandra Ximena, Uribe Molano, Juan David, Zabaleta Polo, Yulieth María, Canchila Paternina, Gladys Mercedes, Forero Romero, Andres Felipe, Caicedo Buitrago, Nestor David, Martinez del Valle, Anacaona, Gutiérrez Paternina, Juan José, San Juan, Juan Felipe, Quintairos, Amanda, Quintero Villarreal, Agamenon, Echeverri, Juan Luis, Negrete Perez, Heinznel, Miranda Bucheli, Alfredo, Navarro, Stella Maria, González Ramírez, Melissa, Velasquez Trujillo, Paula, Rojas Suarez, Jose Antonio, Vasco Ramírez, Mauricio, Garzón Palacios, Laura Niyereth, Medina Lombo, Ronald Antonio, Riascos, Aldemar José, Oyola Yepes, Antonio José, Torres Grande, Andrés Felipe, Tous, Rafael Andrés, Chica Meza, Carmen Lucia, Gómez Vanegas, Carmen Lorena, Rodríguez Mendoza, Laura Vanessa, Castro Gonzalez, Adriana Jazmin, Jaime, Lucía Patricia, Paredes, Bibiana, Hurtado Laverde, Johanna, Oeding Angulo, Guillermo Federico, Ruiz, Guillermo Ortiz, Cáceres, Eder Leonardo, López Rubio, Ana Gabriela, Gómez Carrillo, María Paula, Cárdenas León, Gelen Dayana, Luna, Jhonnatan Castro, Quintero, Diana, Izquierdo, Ledys, Tejada, Diego, Vargas Ordoñez, Monica Patricia, Herrera, Jhojan Sebastián, Castaño Zarur, Eliana Josefa, López Rubio, Ana Gabriela, Mogollón, Pilar, Trochez Rodriguez, Maria del Socorro, Cubillos, Viviana, Rodriguez, Johanna, Lizarazo, Angelica
Publikováno v:
Acta Colombiana de Cuidado Intensivo; 20240101, Issue: Preprints
